![John Yee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Yee
Direktor/Vorstandsmitglied bei
TEMPEST THERAPEUTICS, INC.
Profil
John David Yee is currently Director at Comera Life Sciences, Inc., Director at Tempest Therapeutics, Inc. starting in 2026, and Senior Vice President-Medical Affairs at Apnimed, Inc. since 2023.
Former roles include Independent Director at Comera Life Sciences Holdings, Inc. from 2022 to 2023, Senior VP & Head-Medical Affairs at Vertex Pharmaceuticals, Inc. from 2017 to 2019, Vice President & Head-Medical Affairs at Genzyme Corp.
from 2003 to 2011, Senior Vice President-Medical Affairs at Flexion Therapeutics, Inc. from 2019 to 2020, Vice President-Global Medical Affairs at Intarcia Therapeutics, Inc. from 2016 to 2017, and Chief Medical Officer at Sobi, Inc. from 2020 to 2023.
Education includes a doctorate from Harvard Medical School, graduate studies at Harvard T.H.
Chan School of Public Health, and undergraduate studies at Harvard College.
Aktive Positionen von John Yee
| Unternehmen | Position | Beginn |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 04.06.2026 |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Direktor/Vorstandsmitglied | - |
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Engages in discovering of novel pharmacologic therapies for sleep apnea and related disorders | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2023 |
Ehemalige bekannte Positionen von John Yee
| Unternehmen | Position | Ende |
|---|---|---|
| COMERA LIFE SCIENCES HOLDINGS, INC. | Direktor/Vorstandsmitglied | 03.01.2023 |
Sobi, Inc.
 Sobi, Inc. Medical DistributorsDistribution Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
| FLEXION THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
| VERTEX PHARMACEUTICALS INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 |
Ausbildung von John Yee
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apnimed, Inc.
Apnimed, Inc. BiotechnologyHealth Technology Engages in discovering of novel pharmacologic therapies for sleep apnea and related disorders | Health Technology |
Sobi, Inc.
Sobi, Inc. Medical DistributorsDistribution Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Distribution Services |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Health Technology |
Comera Life Sciences Holdings, Inc.
 Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Wählen Sie MarketScreener 
